Business Wire

Penumbra Augments Vascular Franchise with Latest Indigo System Launch and Expands Medical/Scientific Leadership

Launches Indigo ® System Lightning™ 12 in U.S. Appoints Corey L. Teigen, M.D., as Chief Scientific Officer and James F. Benenati, M.D., FSIR, as Chief Medical ...
Nasdaq

Penumbra’s Newest Generation of Indigo Aspiration System Receives FDA Clearance for Pulmonary Embolism

Pulmonary embolism, or PE, is a deadly condition causing blood clots within a patient’s lungs that has grown in prevalence during the COVID-19 pandemic. The Indigo Aspiration System with Lightning 12 ...
Nasdaq

Penumbra Announces U.S. Commercial Availability of INDIGO System Lightning 7

Offering a new option for physicians to address arterial thrombus removal, the Indigo System Lightning 7 combines the new Indigo System CAT™7 Aspiration Catheter with Lightning Intelligent Aspiration ...
Business Wire

Penumbra Receives FDA Clearance for RED 62 Reperfusion Catheter, Enabling Physicians to Address Broad Range of Stroke Patients

Now available in the U.S., RED ™ 62 is engineered with optimized trackability to help navigate the complex distal vessel anatomy in the brain and deliver powerful aspiration for the removal of blood ...
EurekAlert!

Study supports use of aspiration as frontline thrombectomy therapy for acute ischemic stroke

HOUSTON - Feb. 22, 2017 - Penumbra, Inc. (NYSE: PEN), a global interventional therapies company, today announced the presentation of the results of the ASTER Trial, the first independent, prospective, ...
Seeking Alpha

Penumbra Introduces the Ruby® XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization

ALAMEDA, Calif., June 5, 2025 /PRNewswire/ -- Penumbra, Inc (PEN). (NYSE: PEN) announced the U.S. Food and Drug Administration (FDA) clearance and launch of the Ruby ® XL System, the longest, largest ...
EurekAlert!

Randomized penumbra 3D trial of next generation stent retriever meets primary endpoints

BOSTON, Mass. - July 27, 2016 - Penumbra, Inc. (NYSE: PEN), a global interventional therapies company, today announced that the Penumbra 3D Trial successfully met the primary trial endpoints, ...
Seeking Alpha

Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke

ALAMEDA, Calif., Oct. 14, 2024 /PRNewswire/ -- Penumbra, Inc (PEN). (NYSE: PEN), the world's leading thrombectomy company, announced the completion of enrollment in its THUNDER clinical study for ...
The Motley Fool

Why Penumbra Stock Zoomed 4% Higher Today

The medical device specialist completed enrollment for a clinical trial of its latest thrombectomy product. This addresses a significant medical challenge at a time when the U.S. population is aging.
FierceBiotech

Penumbra eclipses traditional physical therapy with VR-based full body rehab system

Major tech companies like Meta and Microsoft are already building out their virtual worlds to offer new ways of gaming, shopping, working and communicating—and now, physical and occupational therapy ...
Medical Xpress

Randomized penumbra 3-D trial of next generation stent retriever meets primary endpoints

Today during the Society of NeuroInterventional Surgery's (SNIS) 13th Annual Meeting, SNIS President Donald Frei, MD, announced that the Penumbra 3D Trial successfully met the primary trial endpoints, ...